Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Market Closed - Nyse
Other stock markets
 01:30:01 02/05/2024 am IST 		5-day change 1st Jan Change
71.12 USD -0.89% Intraday chart for Prestige Consumer Healthcare Inc. +1.41% +16.17%
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene
Prestige Consumer Healthcare Unit Recalls One Lot of Anesthetic Spray Due to Benzene Presence
Prestige Consumer Healthcare Unit Recalls 2 Lots of Antifungal Spray Powder Due to High Levels of Benzene
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Prestige Consumer Healthcare Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024
Prestige Consumer Healthcare Insider Sold Shares Worth $149,657, According to a Recent SEC Filing
Insider Sell: Prestige Consumer Healthcare
Prestige Consumer Healthcare Fiscal Q1 Earnings Fall, Revenue Rises; Fiscal-Year 2024 Outlook Reaffirmed
Prestige Consumer Healthcare Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Prestige Consumer Healthcare Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024
Prestige Consumer Healthcare Inc. Announces Not Stand for Re-Election of Christopher J. Coughlin as Director
Insider Sell: Prestige Consumer Healthcare
Insider Sell: Prestige Consumer Healthcare
Prestige Consumer Healthcare Rises After Fiscal Q4 Adjusted Earnings, Revenue Climb
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBH Stock
  4. News Prestige Consumer Healthcare Inc.
  5. Other languages